| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.079 | 0.09 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.09 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |